☆ 4.7 Article

Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes A Randomized Clinical Trial

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing A Cluster Randomized Clinical Trial

Srinath Adusumalli et al.

Summary: This study found that interventions targeting both clinicians and patients, such as providing follow-up reminders for patients and patient-specific prompts for clinicians, significantly increased initiation of statin prescriptions during primary care visits. However, sending prompt messages to patients alone did not effectively increase their prescription rates.

JAMA CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network

Alexander J. Blood et al.

Summary: This study implemented and evaluated a remote hypertension and cholesterol management program in a diverse healthcare network. The program resulted in improved blood pressure and cholesterol control among patients, regardless of their race, ethnicity, or primary language.

JAMA CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE)-Diabetes: rationale and design

Adam J. Nelson et al.

Summary: There is a lack of utilization of proven medications for reducing cardiovascular events in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. The COORDINATE-Diabetes trial aims to identify strategies to improve the implementation and adoption of evidence-based therapies. The trial involves a multifaceted intervention in cardiology clinics, focusing on evidence-based care for patients with type 2 diabetes.

AMERICAN HEART JOURNAL (2023)

Add to Collection

Article Endocrinology & Metabolism

Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023

Nuha A. ElSayed et al.

DIABETES CARE (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

Joshua J. Joseph et al.

Summary: This scientific statement highlights the importance of controlling cardiovascular risk factors in reducing cardiovascular events in patients with diabetes. It analyzes how newer antihyperglycemic agents, blood pressure control, and lipid-lowering therapies can improve glycemic control and prevent cardiovascular disease in diabetes. Additionally, it emphasizes the significance of lifestyle interventions, pharmacological therapy, and surgical interventions in managing obesity and metabolic syndrome, which are important precursors of diabetes and comorbid cardiovascular disease. Furthermore, it explores the critical role of social determinants of health and health equity in the continuum of care for diabetes and cardiovascular disease.

CIRCULATION (2022)

Add to Collection

Article Medicine, General & Internal

Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

Adam J. Nelson et al.

Summary: Based on a study in the US, evidence-based therapies for cardiovascular risk reduction are generally underused among patients with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD). The findings suggest that multifaceted interventions are needed to overcome barriers to the implementation of evidence-based therapies and facilitate their optimal use.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice A Cluster Randomized Trial

Lama Ghazi et al.

Summary: Using targeted and tailored electronic health record (EHR) alerts to recommend guideline-directed medical therapy (GDMT) in eligible patients with heart failure with reduced ejection fraction (HFrEF) can significantly increase GDMT use within 30 days.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Lessons Learned From a Patient-Centered, Team-Based Intervention for Patients With Type 2 Diabetes at High Cardiovascular Risk: Year 1 Results From the CINEMA Program

Ian J. Neeland et al.

Summary: This article presents the results of a study on team-based care for patients with type 2 diabetes. The study shows that team-based care can reduce cardiovascular risk factors and improve patients' quality of life.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis

Darren K. McGuire et al.

Summary: SGLT2 inhibitors were found to reduce the risk of major adverse CV events and showed significant heterogeneity in associations with CV death. The most consistent benefit of this class of drugs was a reduction in risk for heart failure and kidney outcomes, with heart failure risk reduction being the most consistent observation across the trials.

JAMA CARDIOLOGY (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes

Merrill Thomas et al.

Summary: Additional digital content is available within the text.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease

Adam J. Nelson et al.

Summary: This study revealed significant gaps in the use of evidence-based therapies among patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. Data showed that only a small proportion of patients were using all three evidence-based therapies, while a substantial number were not using any of them. There is a call to action for patients, providers, industry, regulators, professional societies, and payers to work together to close these care gaps.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Add to Collection

Review Endocrinology & Metabolism

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Naveed Sattar et al.

Summary: The meta-analysis showed that GLP-1 receptor agonists can reduce the risk of major adverse cardiovascular events, all-cause mortality, hospital admission for heart failure, and worsening kidney function in patients with type 2 diabetes, regardless of structural homology.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Francesco Cosentino et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

Sandeep R. Das et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Medication Co-payment Vouchers on P2Y(12) Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction The ARTEMIS Randomized Clinical Trial

Tracy Y. Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Article Statistics & Probability

Untitled

INTERNATIONAL STATISTICAL REVIEW (2017)

Add to Collection

Article Medicine, General & Internal

A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial

Dragos Vinereanu et al.

LANCET (2017)

Add to Collection

Review Cardiac & Cardiovascular Systems

ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Wiley V. Chan et al.

CIRCULATION (2017)

Add to Collection

Article Peripheral Vascular Disease

Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis

Sebastien Foulquier et al.

JOURNAL OF HYPERTENSION (2014)

Add to Collection

Article Medicine, General & Internal

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

N. Sarwar et al.

LANCET (2010)

Add to Collection

Article Medicine, General & Internal

Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

LANCET (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.